Innomar Strategies Celebrates 15 Years of Patient Care Excellence
June 20, 2016
This year, Innomar Strategies is pleased to celebrate its 15th anniversary! The company was founded in 2001 by current president, Guy Payette, and his collaborating partners. Guy had the desire to make a difference in the way healthcare was delivered in Canada, and envisioned a model that integrated key patient support services throughout the entirety of a patient’s treatment journey. As a result, the company’s Integrated Model was created to provide a consistent and coordinated experience, and enhanced the quality of care for all patients.
From humble beginnings, the company has grown to a team of over 1,200 associates located across Canada. Our dedicated employees strive to deliver the highest quality support services that optimize patient outcomes through every step of their treatment journey. Due to the organization’s strong dedication to patients, Innomar Strategies is proud to have become Canada’s leading pharmaceutical support provider for specialty products.
To celebrate our company’s 15 year milestone, Innomar Strategies hosted a barbecue lunch for all associates at both our Ontario and Quebec offices. There were gifts and giveaways, and while the food and socializing with colleagues on a sunny afternoon was fun enough, the activities did not stop there.
Innomar is always looking for new ways to give back to our community and the patients we help every day, so a “Dunk Tank” and “Pie Throwing” was arranged to raise money for the for the Heart and Stroke Foundation. We had a lot of volunteers to get soaked or pie’d, and our associates were generous with their donations. From those events alone, we raised over $940 for Heart and Stroke! This is just another way Innomar likes to support their employees and Canadian patients.
Innomar Strategies has been providing essential healthcare services for patients and their families for 15 years in Canada. It has been Innomar’s ability to consistently develop innovative solutions that has helped the company advance commercialization of specialty pharmaceuticals and continue to shape the Canadian healthcare market today.